Orchid Pharma, a proven leader in the international market, is now expanding its horizons into the domestic formulation sector with the launch of Orchid-AMS (Anti-Microbial Solutions)
This new division is committed to delivering cutting-edge antimicrobial solutions, setting new standards in the industry and enhancing healthcare outcomes.
To be the preferred knowledge partner to hospitals – not merely a vendor of antibiotics.
Our team (~ 250 in 2-3 years) is trusted for their commitment to "doing what is right" and "First do no harm" – co-creating win-win solutions that build and enhance the hospital's capacity and capability around Anti Microbial Stewardship.
To be a responsible pharma industry player, that takes on more than its' fair share of responsibility to impact AMR in Indian society, through multi-stakeholder programs.
To measurably impact hospitals efforts to reduce HAIs, AMR and eventually ALOS through improved clinical outcomes.